Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06754722 · ClinicalTrials.gov registry record · NA

Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors

A NA study of Cancer-related Problem/Condition and Health-Related Quality-of-Life, sponsored by 5 Point App.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
1
Study location

NCT06754722 is a NA study of Cancer-related Problem/Condition and Health-Related Quality-of-Life that is actively recruiting participants, run by 5 Point App. The registered enrollment target is 180 participants, above the 96-participant average among 10 other Cancer-related Problem/Condition trials with a reported enrollment target (88% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06754722, a NA study of Cancer-related Problem/Condition and Health-Related Quality-of-Life, is actively recruiting participants, sponsored by 5 Point App.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to evaluate whether EnergyPoints, a mobile phone health app that guides the participant to do self-acupressure, can decrease fatigue and improve sleep. Acupressure consists of applying physical pressure with fingers or a device to small locations on the body called acupoints. * The investigators will conduct this clinical trial remotely, allowing participants to use the app wherever they are. Participation will involve using the app daily while wearing a fitness tracker (a Fitbit) on the wrist, answering questions on the app and online, as well as completing a questionnaire and participating in an online interview at the end of the study. Participants will be assigned by chance to one of two groups. In both groups, participants will have a 1 week baseline week (Week 0) to get used to the Fitbit. Participants in the Immediate Group will start the 6 week trial of EnergyPoints immediately (Week 1). Participants in the Wait-List Group will be on a wait-list for 6 weeks during which time they will wear the Fitbit and answer online questions daily and weekly. At the end of the waiting period (week 7), these participants will begin the 6 week trial of EnergyPoints. * The risks to participating are minimal. There is a small risk of bruising or getting sore at a point where participants apply pressure. As with any mobile app, there is the possibility that electronic information could be viewed by third parties not involved in the study. The investigators cannot promise any benefits from participating in the study. However, it is possible that using acupressure might improve fatigue or sleep. Participants may use any other approaches to improve fatigue and sleep while in the study. A pilot study will be conducted first with 8 participants and 1 week periods (1 week baseline, 1 week waitlist, and 1 week intervention followed by an End of Study Questionnaire and Exit Interview

Interventions

  • OTHER App to guide self-acupressure

Study Locations (1)

New York

  • 5 Point App Inc - New York

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2026-01-15
Est. Completion 2028-12
Phase NA

Sponsor

5 Point App

1 total trials

What the Registry Record Tells You About NCT06754722

The ClinicalTrials.gov registry entry for NCT06754722 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 96-participant average among 10 other Cancer-related Problem/Condition trials with a reported enrollment target (88% higher). The listed sponsor is 5 Point App, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Cancer-related Problem/Condition appearing as the primary indexed condition, and to 1 intervention - of which App to guide self-acupressure is the first listed.

NCT06754722 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06754722 about?

NCT06754722 is a clinical study titled "Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer Survivors". The purpose of the study is to evaluate whether EnergyPoints, a mobile phone health app that guides the participant to do self-acupressure, can decrease fatigue and improve sleep. Acupressure consists of applying physical pressure with fingers or a device to small locations on the body called acupoi...

What is the current status of trial NCT06754722?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2026-01-15. Estimated completion is 2028-12.

What conditions does trial NCT06754722 study?

This clinical trial studies the following conditions: Cancer-related Problem/Condition, Health-Related Quality-of-Life, Sleep Disturbances, Fatigue in Cancer Survivors.

What interventions are being tested in trial NCT06754722?

The interventions under investigation include: App to guide self-acupressure (OTHER).

Who is sponsoring clinical trial NCT06754722?

This trial is sponsored by 5 Point App, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06754722 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer-related Problem/Condition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.